| Sector |
Project |
Investment Opportunity |
Stage of Investment |
| Marketing Platform (CH) |
Complementary Trade |
Private Equity; 3 Mio. CHF |
Start-up |
| Medical Technology (CH) |
Diabetes Therapy |
Private Equity; 20 Mio. CHF |
Clinical Development |
| Cardiology (CH) |
Stent-Technology |
Private Equity; 7 Mio. CHF |
Go to Market |
| Dental Care (CH) |
High-End Dental Care Tech. |
Management buy-in; 40 Mio. CHF |
Expansion through take-over |
| Oncology (US) |
Brachytherapy |
NYSE, OTCBB; 5 Mio. USD |
Clinical Development |
| Implants (CH) |
Smart Medical Implants |
Pre-IPO; 70 - 150 Mio. CHF |
Late Stage CD / Early Growth |
| Dermatology (DE) |
Medicinal Cosmetics |
XTRA; 20 Mio. EUR |
Expansion |
| Stem Cell Technology (CH/BHS) |
Stem Cell Therapy |
Private Equity; 3.5 Mio. CHF |
Expansion / Clinical Development |
